Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 358

    1.

    Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.

    Fernández-Real JM, Moreno JM, Chico B, López-Bermejo A, Ricart W.

    Diabetes Care. 2007 Mar;30(3):616-21.PMID: 17327330 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity.

    Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W.

    Diabetes Care. 2007 Mar;30(3):604-8.PMID: 17327328 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.

    Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M.

    Diabetes. 2005 Oct;54(10):2911-6.PMID: 16186392 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.

    Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, Han JF, Zhao Y, Li G, Luo M.

    Diabet Med. 2006 Sep;23(9):967-73.PMID: 16922702 [PubMed - indexed for MEDLINE]Related articles

    5.

    Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores.

    Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W.

    J Clin Endocrinol Metab. 2009 Mar;94(3):982-8. Epub 2008 Dec 30.PMID: 19116239 [PubMed - indexed for MEDLINE]Related articles

    6.

    Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

    Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K.

    Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):544-8.PMID: 17177135 [PubMed - indexed for MEDLINE]Related articles

    7.

    Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass.

    Bosch M, Lopez-Bermejo A, Vendrell J, Musri M, Ricart W, Fernandez-Real JM.

    Diabetologia. 2005 Sep;48(9):1841-3. Epub 2005 Jul 29.PMID: 16052331 [PubMed - indexed for MEDLINE]Related articles

    8.

    Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.

    Marcinkowska M, Lewandowski KC, Lewiński A, Bieńkiewicz M, Basińska-Lewandowska M, Salata I, Randeva HS.

    Endokrynol Pol. 2007 May-Jun;58(3):188-94.PMID: 17940983 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.

    de Boer JF, Bahr MJ, Böker KH, Manns MP, Tietge UJ.

    Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G196-201. Epub 2008 Dec 12.PMID: 19074645 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serum concentration of visfatin in obese women.

    Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Kocełak P, Semik-Grabarczyk E, Holecki M, Dabrowski P, Skorupa A.

    Metabolism. 2007 Aug;56(8):1131-4.PMID: 17618961 [PubMed - indexed for MEDLINE]Related articles

    11.

    Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.

    Böttcher Y, Teupser D, Enigk B, Berndt J, Klöting N, Schön MR, Thiery J, Blüher M, Stumvoll M, Kovacs P.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2725-31. Epub 2006 Apr 24.PMID: 16636125 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

    Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, Ozgurtas T, Bingol S.

    Diabetes Res Clin Pract. 2007 Apr;76(1):24-9. Epub 2006 Sep 7.PMID: 16956691 [PubMed - indexed for MEDLINE]Related articles

    13.

    Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.

    Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, McGehee RE Jr, Fried SK, Kern PA.

    J Clin Endocrinol Metab. 2007 Feb;92(2):666-72. Epub 2006 Nov 7.PMID: 17090638 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.

    Lewandowski KC, Stojanovic N, Press M, Tuck SM, Szosland K, Bienkiewicz M, Vatish M, Lewinski A, Prelevic GM, Randeva HS.

    Diabetologia. 2007 May;50(5):1033-7. Epub 2007 Mar 2.PMID: 17334748 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.

    Sandeep S, Velmurugan K, Deepa R, Mohan V.

    Metabolism. 2007 Apr;56(4):565-70.PMID: 17379018 [PubMed - indexed for MEDLINE]Related articles

    16.

    The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.

    Chen CC, Li TC, Li CI, Liu CS, Lin WY, Wu MT, Lai MM, Lin CC.

    Metabolism. 2007 Sep;56(9):1216-20.PMID: 17697864 [PubMed - indexed for MEDLINE]Related articles

    17.

    Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance.

    Fernández-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W.

    Diabetes Care. 2008 May;31(5):958-63. Epub 2008 Feb 19.PMID: 18285549 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.

    Jin H, Jiang B, Tang J, Lu W, Wang W, Zhou L, Shang W, Li F, Ma Q, Yang Y, Chen M.

    Diabetes Res Clin Pract. 2008 Mar;79(3):412-8. Epub 2008 Jan 31.PMID: 18241953 [PubMed - indexed for MEDLINE]Related articles

    19.

    Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.

    Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R.

    J Clin Endocrinol Metab. 2006 Aug;91(8):3165-70. Epub 2006 May 23.PMID: 16720654 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum visfatin increases with progressive beta-cell deterioration.

    López-Bermejo A, Chico-Julià B, Fernàndez-Balsells M, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM.

    Diabetes. 2006 Oct;55(10):2871-5.PMID: 17003355 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data